securities fraud

Class action lawsuit filed against $EOS alleging securities fraud over undisclosed production delays, quality control issues, and inadequate guidance during Nov 2025-Feb 2026 period.

BellRing Brands faces class action lawsuit alleging materially false sales statements driven by temporary customer inventory rebuilding, not genuine demand.

Four public companies face securities fraud investigations alleging misrepresentation of core operations, product safety, and regulatory compliance.

Law firm files class action against $ZYXIQ over fraudulent overbilling practices. Insurer Travelers seeks $23M; investors can join at no cost by April 21.

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant. Stock crashed 50% following misleading investor claims about approval prospects.

BellRing Brands faces securities fraud class action for failing to disclose inventory issues. Stock plummeted 52% after May and August 2025 negative announcements.

Apollo Global Management faces securities fraud lawsuit alleging executives hid communications with Jeffrey Epstein. Stock declined 16% during relevant period; investor deadline May 1, 2026.

Ultragenyx faces securities lawsuit after setrusumab Phase 3 trial failure. Stock fell 42%. Investors must apply for class action lead plaintiff status by April 6, 2026.

Saxena White filed expanded securities class action against Kyndryl for allegedly misleading investors on free cash flow metrics across an 18-month period amid governance failures.

Driven Brands faces securities lawsuit after disclosing material financial statement errors. Stock fell 40% following February 2026 announcement; investors have until May 8 to file.

Kyndryl faces securities fraud lawsuit after revealing internal control weaknesses and executive departures. Stock plunged 55% to $10.59; investor deadline April 13, 2026.

Law firm Kahn Swick & Foti alleges Soleno Therapeutics failed to disclose material safety concerns with its flagship DCCR product, with lead plaintiff applications due May 5, 2026.

Trip.com faces securities fraud lawsuit after China's antitrust probe; stock plunged 19.4% with investors losing $12.90 per share initially.

Navan faces class action lawsuit alleging failure to disclose 39% surge in marketing costs to $95M in Q3 2025 during October IPO, with lead plaintiff applications due April 24, 2026.

Schall Law Firm launches securities fraud lawsuit against Alight ($ALIT) for alleged misstatements on operations and dividends; investors urged to join by May 15, 2026.

Schall Law Firm seeks investors in Oddity Tech Ltd. who bought shares Feb 2025-Feb 2026 for securities fraud lawsuit over false statements regarding customer acquisition costs.

Trip.com faces securities class action over antitrust risk disclosure failures. Stock fell 19.4% after China announced investigation; lead plaintiff deadline set for May 11, 2026.

Law firm Robbins LLP investigates Apollo Global Management for failing to disclose leadership's Jeffrey Epstein communications, following February 2026 media reports that triggered significant stock decline.

Rosen Law Firm investigates $LU for alleged securities violations following auditor removal announcement and delayed financial reporting, which sparked significant shareholder losses.

Pomerantz Law Firm investigates $ARQ for alleged securities fraud following March earnings miss and GAC production pause announcement.